Americhem increases investment in medical modified plastics in China

On November 30, Americhem announced that it will continue to increase the research and development and application research of high-performance materials in China, highlight the product characteristics and advantages of its medical device modified materials, improve the professionalism and recognition of the overall service, and the proportion of the medical modified materials business in the overall related business entities within three years
.

Stanley, Vice President/Managing Director, Asia Pacific, Americhem Teoh explained: "We are very optimistic about the long-term positive development trend of China's medical and general health industry, and are determined to rely on our expertise in the field of polymer materials to grow with this industry, empower the development of China's medical industry, and help Chinese medical device manufacturers connect with international standards
.
" ”

Americhem's Medical Modified Materials business focuses on helping medical device manufacturers meet and optimize product performance and provide innovative material solutions
.
At the same time, Americhem can also provide customers with one-stop technical and service support, including biocompatibility testing, medical certification compliance regulatory consultation, etc
.
In addition, its global presence can also share global advanced professional experience with Chinese customers, enabling Chinese medical device manufacturers to quickly achieve integration
with global standards.